ETF Holdings Breakdown of ARDX

Stock NameArdelyx Inc
TickerARDX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0396971071
LEI549300F542QR4SXHCY32

News associated with ARDX

126,530 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Acquired by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 126,530 shares of the biopharmaceutical company’s stock, valued at approximately $642,000. Tudor Investment Corp ET AL owned about […] - 2025-05-08 09:12:50
First Trust Advisors LP Sells 305,383 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
First Trust Advisors LP lowered its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 53.2% during the fourth quarter, Holdings Channel reports. The fund owned 268,924 shares of the biopharmaceutical company’s stock after selling 305,383 shares during the period. First Trust Advisors LP’s holdings in Ardelyx were worth $1,363,000 at the end […] - 2025-05-07 08:15:07
Ardelyx (NASDAQ:ARDX) Stock Price Down 8.4% Following Insider Selling
Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) shares dropped 8.4% during trading on Monday after an insider sold shares in the company. The stock traded as low as $3.89 and last traded at $3.79. Approximately 3,550,524 shares were traded during trading, a decline of 18% from the average daily volume of 4,347,468 shares. The stock […] - 2025-05-07 05:23:00
Raymond James Financial Inc. Takes Position in Ardelyx, Inc. (NASDAQ:ARDX)
Raymond James Financial Inc. bought a new stake in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 183,490 shares of the biopharmaceutical company’s stock, valued at approximately $930,000. Several other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings […] - 2025-05-06 07:36:46
Ardelyx (NASDAQ:ARDX) Lowered to “Sell” Rating by StockNews.com
StockNews.com cut shares of Ardelyx (NASDAQ:ARDX – Free Report) from a hold rating to a sell rating in a report released on Monday. Other analysts have also recently issued research reports about the stock. LADENBURG THALM/SH SH reissued a “buy” rating and issued a $11.00 price target on shares of Ardelyx in a research note […] - 2025-05-06 05:56:44
Wedbush Estimates Ardelyx’s Q4 Earnings (NASDAQ:ARDX)
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Equities research analysts at Wedbush boosted their Q4 2025 earnings estimates for Ardelyx in a research report issued on Friday, May 2nd. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings per share of $0.01 for the quarter, up from their previous estimate of […] - 2025-05-05 07:24:50
Barclays PLC Sells 14,671 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
Barclays PLC reduced its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 532,654 shares of the biopharmaceutical company’s stock after selling 14,671 shares during the period. Barclays PLC’s holdings […] - 2025-05-01 08:12:53
LPL Financial LLC Has $704,000 Position in Ardelyx, Inc. (NASDAQ:ARDX)
LPL Financial LLC lessened its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 29.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 138,804 shares of the biopharmaceutical company’s stock after selling 58,562 shares during the period. LPL Financial LLC’s holdings in Ardelyx were worth […] - 2025-04-23 07:18:48
CreativeOne Wealth LLC Takes $274,000 Position in Ardelyx, Inc. (NASDAQ:ARDX)
CreativeOne Wealth LLC purchased a new position in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 53,993 shares of the biopharmaceutical company’s stock, valued at approximately $274,000. Other institutional investors and hedge funds have also […] - 2025-04-21 08:13:01
Ardelyx Sees Unusually Large Options Volume (NASDAQ:ARDX)
Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Investors purchased 12,093 put options on the company. This is an increase of 411% compared to the typical volume of 2,365 put options. Insider Activity at Ardelyx In other news, Director David M. Mott bought 199,000 shares of […] - 2025-04-11 05:38:57
Ardelyx, Inc. (NASDAQ:ARDX) Shares Acquired by Teacher Retirement System of Texas
Teacher Retirement System of Texas grew its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 19.1% in the 4th quarter, HoldingsChannel reports. The firm owned 69,867 shares of the biopharmaceutical company’s stock after acquiring an additional 11,191 shares during the quarter. Teacher Retirement System of Texas’ holdings in Ardelyx were worth $354,000 […] - 2025-04-01 07:44:44
Cibc World Markets Corp Makes New $112,000 Investment in Ardelyx, Inc. (NASDAQ:ARDX)
Cibc World Markets Corp purchased a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,015 shares of the biopharmaceutical company’s stock, valued at approximately $112,000. A number of other hedge funds and other […] - 2025-03-28 08:48:47
Ardelyx (NASDAQ:ARDX) Upgraded at Cantor Fitzgerald
Ardelyx (NASDAQ:ARDX – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports. Other research analysts also recently issued research reports about the company. Citigroup decreased their price objective on Ardelyx from $12.00 to $10.00 and set a “buy” rating on […] - 2025-03-06 08:20:02
Ardelyx, Inc. (NASDAQ:ARDX) Receives $9.93 Consensus Price Target from Brokerages
Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned a consensus rating of “Buy” from the nine brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating on […] - 2025-02-28 06:26:55

ARDX institutional holdings

The following institutional investment holdings of ARDX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 183,365USD 667,449
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 23,018USD 83,786
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 111,669USD 406,475
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 111,669USD 406,475 -1.6%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 548USD 1,995
Total =430,269 USD 1,566,180
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.